Related Experiment Video
Updated: Jul 6, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Antibodies as drugs-a Keystone Symposia report
Jennifer Cable1, Erica Ollmann Saphire2,3, Adrian C Hayday4,5,6
1PhD Science Writer, New York, New York, USA.
Experts gathered to discuss the latest advancements in therapeutic antibodies, covering drug development, engineering, and novel applications in oncology and autoimmune diseases.
Area of Science:
- Immunology and Biotechnology
- Drug Discovery and Development
Background:
- Therapeutic antibodies are crucial for treating diverse diseases including cancer and autoimmune conditions.
- Ongoing research focuses on discovering new antibodies and enhancing existing ones.
Purpose of the Study:
- To present the state-of-the-art in antibody therapeutics.
- To highlight advancements in antibody repertoires, deep learning, and bispecific antibody engineering.
Main Methods:
- A Keystone symposium convened experts from academia and industry.
- Presentations covered cutting-edge research in antibody engineering and design.
Main Results:
- The symposium showcased progress in identifying novel therapeutic antibodies.
- Discussions emphasized innovative methods for antibody improvement and de novo design.
Conclusions:
- The field of antibody therapeutics is rapidly evolving with significant advancements.
- Continued research and collaboration are key to unlocking the full potential of antibody drugs.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
Related Concept Videos
Humoral Immune Responses
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Cross-reactivity
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...